CVRx adds $12 million from DaVita HealthCare and others to its $42 million Series F round. CVRx said it added $12 million from DaVita HealthCare, Ysios Capital and others to its Series F funding round, taking the total for the round to $42 million. The Minneapolis-based company is planning to use the money to advance clinical trials and expand its international commercial footprint, according to a press release.
Help employers find you! Check out all the jobs and post your resume.
